Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis
- PMID: 6404993
- DOI: 10.1093/infdis/147.4.744
Proteases of Pseudomonas aeruginosa in patients with cystic fibrosis
Abstract
Radioimmunoassays were used to determine titers of antibody to alkaline protease (AP) and elastase (Ela) produced by Pseudomonas aeruginosa in sera and bronchial secretions, in vitro production of AP and Ela by P. aeruginosa isolates, and occurrence of these enzymes in bronchial secretions from patients with cystic fibrosis. Titers of serum antibodies to AP ranging from 1:10 to 1:545 and to Ela ranging from 1:10 to 1:725 were found in 83%-88% of patients with cystic fibrosis and chronic lung infections due to P. aeruginosa. Antibody titers in liquified bronchial secretions were approximately 10% of the serum titers. Thirty-one (93%) of 34 isolates produced both proteases in vitro in comparable amounts (concentration of protease in culture supernatant: AP, 0.01-480 micrograms/ml; Ela, 0.02-490 micrograms/ml). AP and Ela were detected in vivo when antibodies to the enzymes were absent. The results suggest that specific immune responses in patients with cystic fibrosis neutralize proteases of P. aeruginosa.
Similar articles
-
Longitudinal study of immune response to Pseudomonas aeruginosa antigens in cystic fibrosis.Infect Immun. 1983 Oct;42(1):197-201. doi: 10.1128/iai.42.1.197-201.1983. Infect Immun. 1983. PMID: 6413411 Free PMC article.
-
Detection of proteases of Pseudomonas aeruginosa in immune complexes isolated from sputum of cystic fibrosis patients.Acta Pathol Microbiol Immunol Scand C. 1984 Oct;92(5):307-12. doi: 10.1111/j.1699-0463.1984.tb00092.x. Acta Pathol Microbiol Immunol Scand C. 1984. PMID: 6440414
-
Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patients.Pediatr Pulmonol. 2007 Mar;42(3):249-55. doi: 10.1002/ppul.20562. Pediatr Pulmonol. 2007. PMID: 17243185
-
Pulmonary disease associated with Pseudomonas aeruginosa in cystic fibrosis: current status of the host-bacterium interaction.J Infect Dis. 1985 Apr;151(4):575-80. doi: 10.1093/infdis/151.4.575. J Infect Dis. 1985. PMID: 3919113 Review. No abstract available.
-
Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.APMIS Suppl. 2003;(116):1-47. APMIS Suppl. 2003. PMID: 14692154 Review.
Cited by
-
Bacteria associated with obstructive pulmonary disease elaborate extracellular products that stimulate mucin secretion by explants of guinea pig airways.Am J Pathol. 1986 Dec;125(3):501-14. Am J Pathol. 1986. PMID: 3099581 Free PMC article.
-
Pseudomonas aeruginosa cross-colonization and persistence in patients with cystic fibrosis. Use of a DNA probe.Epidemiol Infect. 1989 Apr;102(2):205-14. doi: 10.1017/s0950268800029873. Epidemiol Infect. 1989. PMID: 2495226 Free PMC article.
-
Secretion of proteases by Pseudomonas aeruginosa biofilms exposed to ciprofloxacin.Antimicrob Agents Chemother. 2005 Aug;49(8):3281-8. doi: 10.1128/AAC.49.8.3281-3288.2005. Antimicrob Agents Chemother. 2005. PMID: 16048937 Free PMC article.
-
[Significance of Pseudomonas aeruginosa virulence factors in acute and chronic Pseudomonas aeruginosa infections].Infection. 1987 Jan-Feb;15(1):47-50. doi: 10.1007/BF01646122. Infection. 1987. PMID: 3106228 German.
-
Transferrin and lactoferrin undergo proteolytic cleavage in the Pseudomonas aeruginosa-infected lungs of patients with cystic fibrosis.Infect Immun. 1993 Dec;61(12):5049-55. doi: 10.1128/iai.61.12.5049-5055.1993. Infect Immun. 1993. PMID: 8225581 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical